Thursday, May 18, 2017
- 5:30PM-7:00PM
-
Abstract Number: 159
Preferences and Satisfaction in a Pediatric Multi-specialty Infusion Center
Quality, Health Services and Education Research Poster Session- 5:30PM-7:00PM
-
Abstract Number: 81
Preliminary Consensus Treatment Plans for Periodic Fever, Aphthous Stomatitis, Pharyngitis and Adenitis: The Foundation for Capturing Treatment Responses in PFAPA from the CARRA PFAPA Subcommittee
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 122
Presenting Manifestations of Amplified Musculoskeletal Pain Syndrome in Males versus Females
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 56
Prevalence of Serum 14-3-3η in Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 158
Quality of Referral Letters to Pediatric Rheumatology and Its Impact on Access to Care
Quality, Health Services and Education Research Poster Session- 5:30PM-7:00PM
-
Abstract Number: 57
Quantification of Dynamic MRI examinations in Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 67
Relapse and Remission in Children with Chronic Non-Infectious Uveitis Treated with Methotrexate and Tumor Necrosis Factor-α Inhibitors
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 110
Risk Factors for Poor Health-Related Quality of Life in Children with Inflammatory Brain Diseases
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 90
Risk of Serious Infections in Juvenile Dermatomyositis patients treated with biological response modifiers including rituximab and abatacept
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 104
Rituximab Treatment for Chronic Steroid-Dependent Henoch-Schonlein Purpura
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 45
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn’s Disease
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 121
Safety Of Biological Response Modifiers In Childhood Autoimmune Rheumatic Diseases From A Single North Indian Centre
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 151
Severe Phenotype of Mevalonate-kinase Deficiency in the Czech Republic
Genetics and Pathogenesis Poster Session- 5:30PM-7:00PM
-
Abstract Number: 59
Six Minute Walk Test in Children with Juvenile Idiopathic Arthritis
Clinical and Therapeutic Poster Session- 5:30PM-7:00PM
-
Abstract Number: 160
Stepping Stones to Transition Smartly